News

Kimberly-Clark introduces new Poise product

BY Michael Johnsen

DALLAS — Kimberly-Clark on Thursday launched the Poise Hourglass Shape pads, a premium line extension, offering a curved shape that improves fit.

The new Poise product is especially designed to meet the needs of women with light bladder leakage who experience difficulty with the fit and performance of traditional protective pads. The new Poise Hourglass Shape pads have innovative "stand-up" leak shields that help eliminate gaps and an absorbent core that offers the excellent protection the Poise brand is known for, all in a narrower product. In addition, Poise Hourglass Shape pads have first-of-a-kind "pink lace" graphics and are packed in an attractive pouch for a feminine look and feel.

"Poise Hourglass Shape pads bring breakthrough technology to the world of light bladder leakage," stated Jay Gottlieb, VP North American adult and feminine care for Kimberly-Clark. "This first-of-a-kind product is designed especially to meet the needs of women who are experiencing LBL and have difficulty with the fit of traditional protective pads. Poise Hourglass Shape pads provide the performance women expect from the brand, and now offer a more feminine design these consumers will love." The contoured shape of the new Poise innovation curves around the legs, enhancing the fit around the natural curves of a woman’s body. In K-C consumer research and testing, 83% of women who tried the product said they would buy it. 

The introduction of Poise Hourglass Shape pads will be supported by a multimillion-dollar integrated commercial program that includes print advertising, online marketing and social media, in-store communication, coupons and an aggressive consumer sampling program to encourage  women to trial the new product. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Researcher: Cancer patients ought to confer with doctors on supplement use

BY Michael Johnsen

CHICAGO — Acai berry, cumin, herbal tea, turmeric and long-term use of garlic may negatively impact chemotherapy treatment, according to a new report released Wednesday that originally was presented at the American Society of Clinical Oncology meeting in Chicago this summer.

Researchers from Northwestern Memorial hospital say there is growing evidence that these popular supplements may intensify or weaken the effect of chemotherapy drugs and in some cases, may cause a toxic, even lethal, reaction.

"With the growth of the Internet, patients have better access to information about alternative products and often turn to dietary and herbal supplements to treat their illness because they think they’re natural and safe," stated June McKoy, geriatrician at Northwestern Memorial Hospital and lead investigator on the ASCO presentation. "What people don’t realize
is that supplements are more than just vitamins and can counteract medical therapies if not taken appropriately."

McKoy suggested more research is needed to understand which supplements interact with chemotherapy drugs and the extent of those interactions, and encourages patients to openly communicate with their physicians about the use of supplements.

"Patients need to tell their doctors what medications they are taking — including vitamins and supplements — to avoid any possible interaction," she said. Recent research found that half of patients undergoing chemotherapy did not tell their doctors they were taking alternative therapies. "Some believe it’s not important, while others are uncomfortable admitting they are pursuing alternative therapies," McKoy said. "The truth is, integrative approaches can be beneficial for cancer patients, but it’s important to take these approaches at the right time and under the supervision of your doctor."

McKoy plans to launch a pilot study this fall to examine how frequently conversations about supplements come up between cancer patients and their doctors. "By identifying communication barriers, we can take steps to improve doctor patient communication in order to prevent potentially dangerous drug interactions," she said. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

J&J adds pain drug resources to responsible prescribing site

BY Alaric DeArment

RARITAN, N.J. — Johnson & Johnson has launched several new tools on a website aimed at ensuring patients with pain get the drugs they need while staying safe.

J&J subsidiary Janssen Pharmaceuticals added resources and tools to PrescribeResponsibly.com for physicians and pharmacists to support appropriate and responsible treatment of pain. The site was originally launched early last year.

The new materials include pain and risk assessments to help doctors evaluate pain, manage harmful side effects and identify aberrant drug-related behavior, as well as general educational content written by experts.

"Millions of adult Americans suffer with acute or chronic pain," Vanderbilt University psychiatry and anesthesiology professor Steven Passik said. "Determining how to treat pain poses a challenge to both physicians and patients. It is important to ensure that issues often associated with opioid pain medicines — including abuse, addiction, misuse and diversion — do not prevent patients who need relief from having access to appropriate pain treatment."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?